Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,500.00    75.00 (1.38%)
Bid:
5,400.00
Ask:
5,600.00
Spread: 200.00 (3.704%)
Market Cap: £137.13m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Director Changes

17 Jul 2023 07:00

RNS Number : 1447G
Camellia PLC
17 July 2023
 

17th July 2023

 

Camellia Plc

(the "Company")

 

Director changes

 

Camellia Plc is pleased to announce the appointment of Byron Coombs as a director and Chief Executive Officer with effect from 25th September 2023.

 

Byron has extensive experience in the financial and investment management sectors and served as Chief Executive Officer of the Group's private bank, Duncan Lawrie, from 2014 until its sale in 2017, since when Byron has been employed by the Group as Investment Director. Byron is also a Non-executive Director of Julius Baer International Limited, from which position he will resign on 31st December 2023. He has previous non-executive and executive experience at Deutsche Bank UK, RBS Wealth Management, Citibank Private Bank, and Merrill Lynch Debt Markets. Byron's appointment follows an extensive candidate search.

 

Camellia's Chairman, Malcolm Perkins, who has also acted as Interim Chief Executive Officer since 1st July 2022, will continue as Interim Chief Executive until Byron Coombs' appointment in September. Malcolm will retire on 30th November 2023 following 51 years' service in the Group. Malcolm has provided outstanding leadership throughout the years; the Company thanks him for his loyalty, contribution and commitment, and wishes him all the very best in his retirement.

 

Simon Turner, currently a Non-executive Director of the Company, will become Non-executive Chairman upon the retirement of Malcolm Perkins. Simon will resign from his position as director of the Camellia Private Trust Company (the trustee of The Camellia Foundation (Bermuda)) and director of Camellia Holding AG, he will remain a trustee of the UK charity primarily funded by The Camellia Foundation and as a nominee of The Camellia Foundation on the Camellia Board. 

 

Stephen Buckland, a nominee of The Camellia Foundation on the Camellia Board, has been appointed a director of the Camellia Private Trust Company (the trustee of The Camellia Foundation (Bermuda)) and director of Camellia Holding AG.

 

The Board will also in due course appoint an additional independent Non-executive Director to increase the number to three, one of whom will be appointed as Senior Independent Director.

 

 

Additional Information

 

In accordance with the AIM Rules, the following information required to be disclosed in relation to the director is set out below. Other than this information, there is no further information required to be disclosed under paragraph (g) of Schedule Two of the AIM Rules.

 

Full name:

Kenneth Byron Coombs (known as "Byron Coombs")

Age:

63

Current beneficial shareholding in the Company:

None

Current directorships:

Julius Baer International Limited

Previous directorships within the last 5 years:

FINHUMF

 

 

 

 

Enquiries

Camellia Plc 01622 746655

Malcolm Perkins, Chairman & Interim CEO

Amarpal Takk, Group General Counsel & Company Secretary

 

Panmure Gordon 020 7886 2500 

Nominated Adviser and Broker 

Emma Earl 

Rupert Dearden

Maitland/AMO 07785 292617

PR 

William Clutterbuck

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPUQUMUPWGUQ
Date   Source Headline
19th Jun 20134:25 pmRNSTransaction in Own Shares
18th Jun 20134:32 pmRNSTransaction in Own Shares
17th Jun 20134:39 pmRNSTransaction in Own Shares
14th Jun 20135:16 pmRNSNotification of Major Interest in Shares
14th Jun 20134:33 pmRNSTransaction in Own Shares
14th Jun 20131:22 pmRNSNotification of Major Interest in Shares
12th Jun 20135:22 pmRNSTransaction in Own Shares
11th Jun 20134:28 pmRNSTransaction in Own Shares - Replacement
11th Jun 201310:45 amRNSTransaction in Own Shares
7th Jun 201310:21 amRNSResult of AGM
7th Jun 201310:12 amRNSRe Joint Venture
6th Jun 201312:30 pmRNSAGM Statement
28th Mar 20137:00 amRNSInterim Management Statement
7th Mar 201312:58 pmRNSDirectorate Change
20th Feb 20132:10 pmRNSNotification of Major Interest in Shares
5th Feb 20133:07 pmRNSNotification of Major Interest in Shares
4th Feb 20132:30 pmRNSNotification of Major Interest in Shares
8th Jan 20131:46 pmRNSDirectorate Change
3rd Jan 201311:16 amRNSDirector/PDMR Shareholding
26th Oct 20123:09 pmRNSRevised Interim Management Statement
26th Oct 20127:00 amRNSInterim Management Statement
3rd Sep 20124:47 pmRNSHalf Yearly Report
30th Aug 20127:00 amRNSHalf Yearly Report
8th Jun 201212:13 pmRNSResult of AGM
7th Jun 201212:17 pmRNSAGM Statement
1st Jun 20129:48 amRNSAnnual Information Update
3rd May 201211:21 amRNSAnnual Report 2011, notice of meeting, proxy form
26th Apr 201212:30 pmRNSFinal Results
30th Mar 20127:00 amRNSInterim Management Statement
26th Oct 20117:00 amRNSInterim Management Statement
8th Sep 201112:44 pmRNSCompany Secretary Change
5th Sep 201111:15 amRNSHalf Yearly Report
25th Aug 201112:00 pmRNSHalf Yearly Report
10th Jun 20112:00 pmRNSResult of AGM
9th Jun 201112:24 pmRNSAGM Statement
2nd Jun 20114:25 pmRNSAnnual Information Update
11th May 20113:27 pmRNSAnnual Report 2010, notice of meeting, proxy form
5th May 20111:12 pmRNSDisposal
28th Apr 201112:47 pmRNSAnnual Financial Report
30th Mar 201112:06 pmRNSInterim Management Statement
11th Jan 20114:35 pmRNSPrice Monitoring Extension
27th Oct 20103:16 pmRNSInterim Management Statement
7th Oct 201010:40 amRNSDisposal
8th Sep 20101:42 pmRNSDisposal
3rd Sep 20103:57 pmRNSDoc re. Interim Report 2010
26th Aug 20109:58 amRNSHalf Yearly Report
7th Jun 201010:46 amRNSResult of AGM
3rd Jun 201012:33 pmRNSAGM Statement
2nd Jun 201010:22 amRNSAnnual Information Update
6th May 20104:06 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.